Read + Share
Amedeo Smart
Independent Medical Education
Hagino T, Saeki H, Kanda N. The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. J Dermatol 2022 Aug 19. doi: 10.1111/1346-8138.16549.PMID: 35986480
Email
LinkedIn
Facebook
Twitter
Privacy Policy